# GLP-1 agonists and biological age

1 paper in the library, strongest Moderate.

**Graded Moderate**: Narrative review drawing on large randomized trials, yet the epigenetic aging data come from a single 32-week trial and no definitive trial has been run.

## Papers (1)

- [Ozempic-Style Drugs May Slow Biological Aging, Not Just Shrink Waistlines](https://longevity-switzerland.com/en/research/ozempic-style-drugs-may-slow-biological-aging-not-just-shrink-waistlines) · Moderate · 2026 · Experimental gerontology

## How this map is computed

A mark's size is the number of papers we hold on that pairing. It is a count, not a weighting by study design or sample size.

The fill shows the strongest grade in the cell. One Strong paper among four Preliminary ones still fills it dark, so open the cell to see the rest.

Grades and verdicts are assigned by a named person, never by counting.

An empty cell is a finding: nobody in our library has run that trial yet.

---

_Canonical: https://longevity-switzerland.com/en/evidence/glp-1/biological-age · Part of Longevity Cities_